Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population
NCT ID: NCT00847340
Last Updated: 2012-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
342 participants
OBSERVATIONAL
2009-12-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives:
1. To determine the HPV genotypes distribution in genital warts in the study population.
2. To assess the knowledge about transmission \& prevention of HPV infection related diseases
3. To determine the direct medical costs of genital warts attention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
NCT06700941
Dynamics of Human PApilloma Virus Interactions; Internet-based Students HeAlth Research Enterprise
NCT01988948
Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile
NCT01483794
The Role of Genital Warts in HIV Acquisition in Peru
NCT01387412
Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment
NCT00941811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Female and male between 18 - 45 years of age living in Bogota, Colombia
Sample frame
Patients attending to gynecologic or STD consult in a mayor out patient clinic in Bogotá (PROFAMILIA)
Analysis
Analysis of the information will be exhaustive. We will calculate prevalence of HPV genotypes in the GW in both sexes separately. Analyses of the survey will include simple frequencies, percentages, and comparison of results related to HPV knowledge with sociodemographic and clinical information. Explorative analysis using parametric or non parametric statistics of the items included in the questionnaire and clinical forms will be done as appropriate. We will calculate the medical cost of patients enrolled in the study. The treatment protocols used for this protocol will reflect the current clinical practice accepted for the treatment of genital warts. We will use national reference cost list (SOAT) to determine the cost of procedures included.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biopsy Excisional
Biopsied from genital warts will be taken through an excisional procedure. Homeostasis will be obtained by using apply of Monsel solution. Biopsied sample will be splinted in order to obtain two pieces, one of them will be frozen (liquid Nitrogen) and designated to the HPV DNA PCR test (GP5, GP6) to be performed at the immunology lab at the National Cancer Institute in Bogotá. The other one will be kept in Formalin solution (10%) and sent to the pathology laboratory for haematoxiline - eosine paint and lecture.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lesions suspicious of being HPV related.
* The main manifestations of anogenital warts include:
* Cauliflower-like condylomata acuminata lesions that usually involve moist surfaces
* keratotic and smooth papular warts, usually on dry surfaces
* subclinical "flat" warts, that can be found on any mucosal or cutaneous surface and, which are probably overseen in the majority of cases.
* Lesions other than the described above, are not to be biopsied, according to the investigator criteria.
Exclusion Criteria
* To be a participant in any HPV vaccine clinical trial study
* Known immune suppressive disease.
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
La Fundacion para la Investigacion y el Desarrollo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gustavo Hernandez-Suarez
MD MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gustavo J. Hernandez-Suarez, MD
Role: PRINCIPAL_INVESTIGATOR
Research & Development Fundation (FID)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
protocol V profamilia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.